JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8618 Palomid 529
2 Citation

Summary: PI3K/Akt/mTOR inhibitor

insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
A8629 DBeQ

Target: P97 ATPase

Summary: P97 ATPase inhibitor

≥16 mg/mL
B2141 Calcitriol
5 Citation

Summary: Active metabolite of vitamin D3

insoluble in H2O; ≥20.83 mg/mL
B2227 BI-D1870
1 Citation

Target: p90 S6K

Summary: P90 RSK inhibitor,ATP-competitive and cell-permeable

insoluble in H2O; ≥19.55 mg/mL
B2277 A-803467
2 Citation

Target: Voltage-gated Sodium (NaV) Channels

Summary: NaV1.8 channel blocker,potent and selective

insoluble in H2O; ≥13.95 mg/mL
B1404 DCC-2036 (Rebastinib)

Target: FLT3|Bcr-Abl|Tie-2|KDR

Summary: Bcr-Abl inhibitor

≥27.7 mg/mL
B1500 I-BET151 (GSK1210151A)
6 Citation

Target: Bromodomain and Extra-Terminal motif (BET)

Summary: Selective BET inhibitor

≥41.5 mg/mL
C5708 α-Guanidinoglutaric Acid

Summary: linear mixed-type inhibitor of nNOS
C5723 S-(2-aminoethyl) Isothiourea (dihydrobromide)

Summary: non-selective inhibitor of all NOS isoforms

≤10 mg/mL
A8764 Rapalink-1
6 Citation

Target: mTOR

Summary: third-generation mTOR inhibitor

≥178.4 mg/mL